Blockchain Registration Transaction Record

Annovis Bio Welcomes New Executive Team Members

Annovis Bio (NYSE: ANVS) announces the addition of four new members to its executive team as it makes strides towards advancing its flagship drug candidate and bringing potential treatments for neurodegenerative disorders closer to market.

Annovis Bio Welcomes New Executive Team Members

This news matters because it signifies a significant step forward for Annovis Bio in its mission to develop transformative therapies for neurodegenerative disorders. The addition of seasoned professionals to the executive team indicates the company's commitment to advancing its drug candidate and bringing potential treatments for Alzheimer's Disease and Parkinson's Disease closer to market.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xcbbbf643c601077a454fb3c16c0b0a2482c7377bbbb6eb1f61e57430638dcc23
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintgulfBoca-045f532f4967b8f9316ee2f30f5a0416